3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Conditions
Diabetes Mellitus, Type 2
1
Cushing Syndrome
1
ACTH Syndrome, Ectopic
1
Interventions
relacorilant
5
Resistance Training
3
Pioglitazone
2
Nutritional Status
2
Metformin
2
saxagliptin
1
pembrolizumab
1
mazdutide
1
dapagliflozin
1
Sitagliptin Phosphate
1
Resistant Starch
1
Plant Proteins
1
Nutrition Assessment
1
Methods
1
Insulin Lispro
1
Insulin Glargine
1
Exercise Movement Techniques
1
Exercise
1
Ethanol
1
Endodontics
1
Educational Status
1
Early Intervention, Educational
1
Diet
1
Continuous Glucose Monitoring
1
Circuit-Based Exercise
1
Cholecalciferol
1
Blood Specimen Collection
1
Ascorbic Acid
1
ASP3662
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Diabetes Mellitus, Type 2
×
ASP3662
×
Clear all
NCT07296484
2026-05-12
CAPTAIN-T2D
Sparrow Pharmaceuticals
Phase 2
Recruiting
1,500 enrolled